Current drug safety

Keyphrases

Publications

2023

M Upadhyay, B Purohit, P Pargi
Oral Linezolid Induced Early Onset Hepatic Encephalopathy- A Case Report of 65-year Old Diabetic Female. Current drug safety (2023)
Yosra Zaimi, Myriam Ayari, Nadine Ghithia, Shema Ayadi
Non-ANCA Leucocytoclasic Vasculitis Induced by Sofosbuvir / Ledipasvir Treatment: A case report. Current drug safety (2023)
Samrat Bose, Shirsendu Mandal, Rajesh Khan, Himangshu Sekhar Maji, Sumel Ashique
Current Landscape on Development of Phenylalanine and Toxicity of its Metabolites- A Review. Current drug safety (2023)
Chunnu Kumar Yadav, Rajat Ranka, Prasan Kumar Panda, Bishal Pratap Shah, Mayank Kumar Mishra, Vijay Krishnan
Amoxicillin induced fever, rash, and catatonia - A case study. Current drug safety (2023)
Renuka Munshi, Miteshkumar Maurya
A Case Report of Cefixime, Paracetamol, and Nimesulide Induced Toxic Epidermal Necrolysis in a Woman with Dengue Infection without any Other Associated Comorbidities. Current drug safety (2023)
Sree Sudha T Y, K S B S Krishna Sasanka, Harminder Singh, Bhumika Meena
A routine Over the counter phenylephrine causing rarer drug eruption as Adverse drug reaction - A case report. Current drug safety (2023)
Kamyar Iravani, Yaaghoob Khosravi, Aida Doostkam, Amir Soltaniesmaeili
Vitamin D Deficiency in Advanced Laryngeal Cancer and its Association with Pharyngocutaneous Fistula Following Total Laryngectomy. Current drug safety (2023)
Shalini Shukla, Priyanka Sharma, Priya Gupta, Shikha Pandey, Reshu Agrawal, Deepak Rathour, Dharmendra Kumar Kewat, Ramu Singh, Sunil Kumar Thakur, Rishi Paliwal, Kunjbihari Sulakhiya
Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India. Current drug safety (2023)
Zainab Najim Abdul-Nabi, Noor Kadhim Mohamed-Jawad, Noor Yousif Fareed, Nadheerah Falih Neama, Falah Hassan Shari
Adverse Effects Post Covid -19 Vaccination and Its Association with Age, Gender and Comorbid Disease in Basrah City Southern of Iraq. Current drug safety (2023)
Namrata Chhabra, P S Meghana Reddy, Ayush Bhatnagar, Satyaki Ganguly
Penicillamine-Induced Stevensjohnson Syndrome-Toxic Epidermal Necrolysis (Sjs-Ten) Overlap In An Hiv-Infected Patient With Wilson's Disease And Hepatitis B. Current drug safety (2023)
Quaedvlieg Hjl, Polderman Fn, Borkent M, De Jonge Hjm, Annema Pa, Derijks Ljj, Sikma Ma, Bethlehem C
The Effect of Renal Replacement Therapy in a Patient with Mercaptopurine Toxicity: Time to Revise Guidelines. Current drug safety (2023)
Ridhi Chhabra, Rachna Gupta, Lalit K Gupta
Sugammadex versus neostigmine for reversal of neuromuscular blockade in adults and children: A systematic review and meta-analysis of randomized controlled trials. Current drug safety (2023)
Badreddine Moukafih, Leila Belaroussi, Sanae Achour, Abdeslam El Kartouti
Side Effects Reported by Moroccan Medical Students Who Received COVID-19 Vaccines. Current drug safety (2023)
André Wieringa, Helle-Brit Fiebrich, Fleur van Gelder, Abraham J Valkenburg, Jan Gerard Maring, Elise J Smolders
Bleeding complications in a patient after the unexpected interaction between valproic acid and phenprocoumon. Current drug safety (2023)
Fatemeh Kouhestani, Maryam Hassanzad, Shadi Baniasadi
Comparing the Efficacy and Safety of Nebulized Gentamicin plus amikacin versus Tobramycin in Patients with Cystic Fibrosis. Current drug safety (2023)
Mouna Daldoul, Ons Charfi, Emna Bouattour, Houda Hammami-Ghorbe, Ahmed Zaiem, Samy Fenniche, Ghozlane Lakhoua, Sihem El Aidli
Pantoprazole Induced Stevens-Johnson Syndrome: A case-report. Current drug safety (2023)
Hitesh Malhotra, Prerna Sharma, Mohammad Amjad Kamal, Peeyush Kaushik, Nidhi Rani
Concise Review on Scientific Approaches to Burns and Scars. Current drug safety (2023)
Preet Amol Singh, Neha Bajwa
Is Tinospora cordifolia Responsible for Drug Induced Liver Injury? Current drug safety (2023)
Omar Yahya Al-Shargi
Prescribing Pattern of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Middle East Region: A Critical Review. Current drug safety (2023)
Lucía González-Bravo, María-José Sánchez-González, José Barbarroja-Escudero, Josefa Monjo-Paz, Dorotea Matas-Dominguez, Melchor Alvarez-Mon
Immediate Reaction to Propranolol: An Extremely Rare but Important Condition. A Case Report. Current drug safety (2023)
Anushka Jain, null Kamini, Mukesh Bansal
Polymeric Micelles as Drug Delivery System: Recent Advances, Approaches, Applications and Patents. Current drug safety (2023)
Jakob Hasselstrøm Jensen, Peter Vestergaard, Morten Hasselstrøm Jensen
Association between Glucose-Lowering Treatments and Risk of Diabetic Retinopathy in People with Type 2 Diabetes: A Nationwide Cohort Study. Current drug safety (2023)
Renzhu Liu, Yixiang Hu, Qingzi Yan, Xiang Liu
Calcium Folate for Reducing the Side Effects of Low-dose Methotrexate in Rheumatoid Arthritis: A Case Report. Current drug safety (2023)
Naman Kumar, Arjun Khora, Riya Loomba, Nikhil Sharma, Abhishek Kumar, Ajay Rana, Rohit Kamboj, Sweta Kamboj, Kumar Guarve, Surya Prakash Guatam
Covid-19 vaccination program for children: An electronic assessment of symptoms. Current drug safety (2023)
Dhanya Jose, Krishna S Nair, Alagesan Murali, Joseph M Pappachan
The Safety and Effectiveness of Antifungal Medications in the Management of Mucormycosis during the COVID-19 Pandemic. Current drug safety (2023)
Elena María Pérez López, Diego Rangel Sousa, Jorge Navarro Roldán
Myocarditis and Pericarditis related to mRNA COVID-19 Vaccination: A Case Report. Current drug safety (2023)
Imen Aouintia, Wiem Daly, Ghozlane Lakhoua, Widd Kaabi, Ons Charfi, Sana Debbeche, Sarrah Kastalli, Ahmed Zaiem, Sihem El Aidli
Development of Dermatomyositis after Pfizer BioNTeh COVID-19 Vaccine: A Case Report. Current drug safety (2023)
Yunhua Xu, Yong Li, Jie Luo, Rong Tang
Osimertinib-induced keratitis and secondary toxic epidermal necrotic drug eruption- A case report and literature review. Current drug safety (2023)
Elham Hosseini, Foroud Shahbazi
Methotrexate-Induced Severe Pancytopenia in a Patient with Rheumatoid Arthritis: A Case Report and Review of Literature. Current drug safety (2023)
Faiza Javed, Anoop Kumar
Identification of signal of clindamycin associated renal failure acute: A Disproportionality Analysis. Current drug safety (2023)
Muhammet Özbilen, Şeyda Tuba Savrun, Ali Aygün, Yasemin Kaya
Ferric Carboxymaltose-Mediated Methemoglobinemia. Current drug safety (2023)
Luqman Nulhakim Bin Said, Loo Shing Chyi, Benodict Apok Anak Talin, Augustine Law Foo Khiong, Izzah Alia Binti Mohamad Rosli, Jessica Low Pei Sze, Ridhwan Bin Abdul Razak
Knowledge, Perception, and Practices on the Labelling of Dispensed Medicine among Community Pharmacists and General Practitioners in the state of Sarawak, Malaysia. Current drug safety (2023)
Behzad Bushehri, Akbar Mokhtarpoor, Ehsan Bahrami, Adel Ghorani-Azam
Cutaneous Adverse Drug Reactions: Regional Experience of a Global Challenge. Current drug safety (2023)
Jasleen Kaur, Supreet Kaur, null Vandana, Raman Deep Singh Narang, Sahib Tej Singh, Danish Khindri
To evaluate the association between serum concentration of vitamin D and chronic periodontitis in non-menopausal females: A clinico biochemical study. Current drug safety (2023)
Morteza Akhzari, Sajad Jalili, Sajad Rashno, Masoumeh Akmali, Hossein Foruozandeh, Mahdi Barazesh
Evaluation of the Antioxidant Effects of Berberine against Sodium Nitrite-induced Oxidative Injury in the Rat Liver. Current drug safety (2023)
Parisa Saberi-Hasanabadi, Reza Sedaghatnejad, Hamidreza Mohammadi
Protective effect of quercetin against paraquat-induced brain mitochondrial disruption in mice. Current drug safety (2023)
Rania Kammoun, Ons Charfi, Ghozlane Lakhoua, Ahmed Zaiem, Riadh Daghfous, Sarrah Kastalli, Imen Aouinti, Sihem El Aidli
Statin associated Muscular Adverse Effects. Current drug safety (2023)
Pugazhenthan Thangaraju, Hemasri Velmurugan, Sree Sudha Ty
Bedaquiline's Safety Profile Monitoring in India: Considerations for Future - A Systematic review.. Current drug safety (2023)
Roopali Mahajan, Jayantee Kalita
Tizanidine induced hypotension: report of a case and review of literature. Current drug safety (2023)
Ons Charfi, Ghozlane Lakhoua, Khouloud Berrim, Sarrah Kastalli, Imen Aouinti, Talel Badri, Riadh Daghfous, Ahmed Zaiem, Sihem El Aidli
Erythema multiforme reactions following Pfizer/BioNTech (tozinameran) vaccination: two case-reports with positive rechallenge and review of the literature. Current drug safety (2023)
Zhijun Xin, Ning Wang, Huaizhou Wang
Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report. Current drug safety (2023)
Naina Mohamed Pakkir Maideen, Ibrahim Ramadan Barakat, AbduRazak Hassan Jumale
Paracetamol (Acetaminophen)-associated SJS, TEN, AGEP, and DRESS Syndromes- A Narrative Review. Current drug safety (2023)
Vasudev Pai, Chandrashekar K S, Aswatha Ram Holavana Halli Nanjundaiah, Venkatesh Kamath, Vijayanarayana Kunhikatta
Issues and challenges in pharmacovigilance of Herbal formulations. Current drug safety (2023)

volume 19, number 1, 2023

Seetal Dodd
Preface. Current drug safety 19 (1) (2023)

volume 18, number 1, 2023

Imran Ibni Gani Rather, Nusrat Shafiq, Avaneesh Kumar Pandey, Ritika Kondel Bhandari, Samir Malhotra, Devinder Kumar Chouhan
Antibiotic Prophylaxis for Orthopaedic Implant Removal: What Does the Evidence Say? Current drug safety 18 (1) (2023)

volume 18, number 2, 2023

Pallavi Kaushik, Mohd Ashif Khan, Nidhi B Agarwal, Aakriti Garg
A Systematic Review on Interferon Alpha-Induced Cognitive Impairment in Hepatitis C Patients. Current drug safety 18 (2) (2023)
Kemisha Sanghvi, Chandrashekar Kodangala Subraya, Vasudev Pai, Aswatha Ram Holavanna Halli Nanjundaiah, Vijayanarayana Kunhikatta
Pharmacovigilance in Herbal Drugs: A Challenge. Current drug safety 18 (2) (2023)
Tauqeer Hussain Mallhi, Yusra Habib Khan, Muhammad Hammad Butt, Muhammad Salman
Self-medication during the Era of COVID-19; Potential Implications for Drug Policy Makers and Pharmacovigilance. Current drug safety 18 (2) (2023)

volume 18, number 3, 2023

Makhlouf Yasmine, Maatallah Kaouther, Kaffel Dhia, Ferjani Hanene, Triki Wafa, Ben Nessib Dorra, Hamdi Wafa
Treatment with Rituximab in Rheumatoid Pneumoconiosis: A Case Report. Current drug safety 18 (3) (2023)
Helmi Ammar, Mouna Ben Sassi, Rim Charfi, Hanene El Jebar, Riadh Daghfous, Emna Gaies, Sameh Trabelsi
Therapeutic Drug Monitoring of Tacrolimus in Tunisian Renal Transplant Patients during the Tuberculosis Infection: A Retrospective, Observational, Single-centre Analysis. Current drug safety 18 (3) (2023)